Body Contouring, Cellulite
Conditions
Brief summary
The purpose of this study is to assess the efficacy of device TRI-ACTIVETM (DEKA M.E.L.A., Itália)in the treatment od cellulite and body contouring.
Detailed description
The present study is a clinical, opened trial and single-center. The patients will be treated by six laser diodes, localised cooling system and rhythmical intake massage device. Application of the massage will be performed for 8 weeks in a total of 16 treatment sessions: twice a week. A set of photographs will be taken at visit 1 (baseline), visit 2 and 3 with standardized positions and lighting conditions.
Interventions
DEVICETRI-ACTIVE LASERDERMOLOGYTM (DEKA M.E.L.A., Itália)
Sponsors
Hexsel Dermatology Clinic
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
1. Written Informed Consent; 2. Subjects agreeing to take part of all procedures of the study (including mechanical massage, photographs), after being fully informed on the objectives and nature of the investigations; 3. Female subjects between 18-45 years; 4. Subjects presenting with cellulite grades I-III on buttocks and thighs; 5. Medical history and physical examination which, based on the investigator's opinion, do not prevent the patient from taking part in the study and use the device under investigation; 6. Female subjects of childbearing age should present a negative urine pregnancy test and should be using an effective contraceptive method (3 months before the enrollement untill the end of the study); 7. Body Mass Index (BMI = weight/height2) beetwen 20,0-25,0; 8. Availability of the subject throughout the duration of the study (60 days); 9. Availability of the subject in maintaining a stable weight during the study (variation less than 2 kg) 10. Subjects with sufficient schooling and awareness to enable them to cooperate to the degree required by this protocol.
Exclusion criteria
1. Pregnant women or women intending to become pregnant during the study (next 3 months); 2. BMI superior 25,0; 3. Subjects with diabetes mellitus, cardiac insufficiency, asthma, or bronchitis; 4. Subjects participating in other clinical trials; 5. Subjects with neoplastic disorders, uncontrolled thyroid disorders or uncontrolled hypertension; 6. Subjects with coagulation disorders, using anticoagulants or tendency of bruises; 7. Subjects with vascular disorders (phlebitis or varicose veins) in the area to be treated; 8. Any prior aesthetic surgery affecting the area to be treated (liposuction, Subcision®), 3 months before the study, that may interfere with results; 9. Any other prior anti-cellulite treatment or body measures treatment, 30 days prior to the study; 10. Subjects with inflammation or active infection in the area to be treated. 11. Subjects with a history of adverse effects, which in the investigator's opinion should prevent the patient from participating in the study; 12. Patients with cutaneous or vascular alterations, that difficult visualization and documentation of cellulite; 13. Subjects with a history of medical treatment non-adherence or showing unwillingness to adhere to the study protocol; 14. Subjects who can not come to the visits (one missing visit/ month is allowed); 15. Subjects intending to initiate any intensive sport; 16. Subjects using analgesics, non-hormonal antiinflammatories, antihistaminics, corticosteroids, or diuretics; 17. Subjects tanned, or intending to expose the area of study to sun, artificial UV, or self-tanning during the study; 18. Any condition that, in the opinion of the investigator, can compromise the evaluation of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of effectiveness of treatment based on current classification of cellulite and evaluation corporal measures | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of subject's satisfaction | — |
| Visual assessments of the treated area before and after treatment | — |
| Safety analysis | — |
Outcome results
None listed